ESMO Media Releases

The Molecular Analysis for Personalised therapy (MAP) Congress is a one-of-a-kind meeting designed to answer the critical question about how to integrate in daily practice the wealth of information coming from the analysis of tumour samples.

ESMO 20^th World Congress on Gastrointestinal Cancer celebrates two decades of clinical progress and examines further promising research

ESMO, the leading European professional organisation for medical oncology, has announced that the ESMO 2020 Annual Congress will take place from 18 to 22 September 2020, at the IFEMA – Feria de Madrid, Spain.

Researchers have shown for the first time that a form of artificial intelligence or machine learning known as a deep learning convolutional neural network (CNN) is better than experienced dermatologists at detecting skin cancer.

Nearly 25,000 participants from all over the world are expected in Munich, Germany, between 19-23 October to attend the leading international oncology event in Europe, the ESMO 2018 Congress

At the 71st World Health Assembly (WHA) in Geneva, Switzerland, ESMO, the leading professional organisation for medical oncology, delivered two statements positioning cancer as a priority on the World Health Organisation’s (WHO) global agenda.

ESMO, the leading professional organisation for medical oncology, shares concerns expressed in a scientific paper and reflected in the international media about the rising costs of cancer medicines.

Investing in the continuity of care for lung cancer patients can bring tremendous benefits in terms of patient satisfaction and quality of life.

Alectinib provides longer symptom improvement than crizotinib in ALK-positive non-small-cell lung cancer (NSCLC), according to results from the ALEX trial presented at the ELCC 2018 (European Lung Cancer Congress) in Geneva, Switzerland.

Further evidence that immunotherapy provides long-term survival benefit for patients with lung cancer was presented today at ELCC 2018 (European Lung Cancer Congress) in Geneva, Switzerland.

ESMO welcomes the latest reports from The Cancer Genome Atlas (TCGA) as a major resource for researchers across the world and calls for increased across-the-board commitment to translate these efforts into medical advances for the benefit of cancer patients.

The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced that the 2018 Heine H. Hansen (HHH) Award will be given to Fabrice Barlesi.